Compare ADMA Biologics Inc (ADMA) vs AGNC Investment Corp (AGNC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs AGNC Investment Corp — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while AGNC Investment Corp trades at $10.91 (market cap $12.91B). The key difference: AGNC Investment Corp is far larger — about 5.8× ADMA Biologics Inc's market cap, and AGNC Investment Corp pays a 13.22% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | AGNC | |
|---|---|---|
Market Cap | $2.22B | $12.91B |
Sector | Health | Financials |
52-Week High | $20.38 | $12.17 |
52-Week Low | $7.60 | $9.46 |
Enterprise Value | $2.29B | — |
Dividend Yield | — | 13.22% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About AGNC Investment Corp
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage or real estate markets.
Read more on AGNC →
